FDA Clearance Tracker · P100030-S008
PreveLeak Surgical Sealant
Last checked: Nov 20, 2026Latest source record: Dec 21, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2017
Approved
Time to decision
171 days
Received Jul 3, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P100030-S008
- Device name
- PreveLeak Surgical Sealant
- Applicant
- Baxter Healthcare Corporation
- Applicant location
- Deerfield Lake, IL
- Received
- Jul 3, 2017
- Decided
- Dec 21, 2017
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100030
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for Preveleak Surgical Sealant. The device is indicated for use in vascular and cardiac reconstructions (excluding application to arterial and venous grafts used in coronary artery bypass graft surgery) to achieve adjunctive hemostasis by mechanically sealing areas of potential leakage.
Source documents
Other decisions for Baxter Healthcare Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251745 · Decided Dec 16, 2025 · 193 days after receipt
Device type: Blood Pressure Cuff (DXQ) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.